Activation of AMP-activated protein kinase prevents lipotoxicity in retinal pericytes

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 6, 2011, Pages 3630-3639

  Cacicedo, José M ^a   Benjachareonwong, Sunun ^a   Chou, Eva ^a   Yagihashi, Norito ^a,b   Ruderman, Neil B ^a   Ido, Yasuo ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HIROSAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; DIACYLGLYCEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OLEIC ACID; PALMITIC ACID; PROTEIN BAX; PROTEIN BCL 2; ACETYLCARNITINE; PALMITIC ACID DERIVATIVE; SPHINGOLIPID;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; COW; DOWN REGULATION; ELECTRON SPIN RESONANCE; FATTY ACID OXIDATION; LIPOTOXICITY; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RETINA; WESTERN BLOTTING; ADENOVIRUS; ANIMAL; CATTLE; CELL CULTURE; CELL PROTECTION; CYTOLOGY; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; RETINA BLOOD VESSEL;

ACETYLCARNITINE; ADENOVIRIDAE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; APOPTOSIS; CATTLE; CELLS, CULTURED; CYTOPROTECTION; DIGLYCERIDES; ELECTRON SPIN RESONANCE SPECTROSCOPY; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IN SITU NICK-END LABELING; NF-KAPPA B; OLEIC ACID; OXIDATIVE STRESS; PALMITATES; PERICYTES; RETINAL VESSELS; SPHINGOLIPIDS;

EID: 80051743229     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5784     Document Type: Article

References (56)

1. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ 2004;82: 844-851.
2. Cogan DG, Toussaint D, Kuwabara T. Retinal vascular patterns, IV: diabetic retinopathy. Arch Ophthalmol. 1961;66:366-378.
3. Dagher Z, Park YS, Asnaghi V, Hoehn T, Gerhardinger C, Lorenzi M. Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathy. Diabetes. 2004;53:2404-2411.
4. Nakamura M, Barber AJ, Antonetti DA, et al. Excessive hexosamines block the neuroprotective effect of insulin and induce apoptosis in retinal neurons. J Biol Chem. 2001;276:43748-43755.
5. Hammes HP, Du X, Edelstein D, et al. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med. 2003;9:294-299.
6. Das Evcimen N, King GL. The role of protein kinase C activation and the vascular complications of diabetes. Pharmacol Res. 2007; 55:498-510.
7. Wautier JL, Schmidt AM. Protein glycation: a firm link to endothelial cell dysfunction. Circ Res. 2004;95:233-238.
8. Chew EY, Ambrosius WT, Davis MD, et al. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med 363:233-244.
9. Sacks FM. After the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: implications for fenofibrate. Am J Cardiol. 2008;102:34L-40L.
10. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest. 2000;106:171-176.
11. Boden G, Shulman GI. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest. 2002;32(suppl 3):14-23.
12. Cacicedo JM, Benjachareowong S, Chou E, Ruderman NB, Ido Y. Palmitate-induced apoptosis in cultured bovine retinal pericytes: roles of NAD(P)H oxidase, oxidant stress, and ceramide. Diabetes. 2005;54:1838-1845.
13. Artwohl M, Roden M, Waldhausl W, Freudenthaler A, Baumgartner-Parzer SM. Free fatty acids trigger apoptosis and inhibit cell cycle progression in human vascular endothelial cells. FASEB J. 2004;18:146-148.
14. Shimabukuro M, Zhou YT, Levi M, Unger RH. Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci U S A. 1998;95:2498-2502.
15. Turpin SM, Lancaster GI, Darby I, Febbraio MA, Watt MJ. Apoptosis in skeletal muscle myotubes is induced by ceramides and is positively related to insulin resistance. Am J Physiol Endocrinol Metab. 2006;291:E1341-E1350.
16. Hickson-Bick DL, Sparagna GC, Buja LM, McMillin JB. Palmitateinduced apoptosis in neonatal cardiomyocytes is not dependent on the generation of ROS. Am J Physiol Heart Circ Physiol. 2002;282:H656-H664.
17. Ruderman NB, Cacicedo JM, Itani S, et al. Malonyl-CoA and AMPactivated protein kinase (AMPK): possible links between insulin resistance in muscle and early endothelial cell damage in diabetes. Biochem Soc Trans. 2003;31:202-206.
18. Kim J, Ahn JH, Kim JH, et al. Fenofibrate regulates retinal endothelial cell survival through the AMPK signal transduction pathway. Exp Eye Res. 2007;84:886-893.
19. Kemp BE, Stapleton D, Campbell DJ, et al. AMP-activated protein kinase, super metabolic regulator. Biochem Soc Trans. 2003;31: 162-168.
20. Hardie DG, Scott JW, Pan DA, Hudson ER. Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett. 2003;546:113-120.
21. Ruderman N, Prentki M. AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome. Nat Rev Drug Discov. 2004; 3:340-351.
22. Ruderman NB, Xu XJ, Nelson L, et al. AMPK and SIRT1: a longstanding partnership? Am J Physiol Endocrinol Metab. 2010;298: E751-E760.
23. Cacicedo JM, Yagihashi N, Adachi T, Ruderman NB, Ido Y. Activation of AMPK by AICAR inhibits palmitate-induced endoplasmic reticulum (ER) stress, increases in ceramide mass, and cytotoxicity in cultured bovine retinal pericytes (BRPC). Diabetes. 2008;57: 806-P.
24. Cacicedo JM, Yagihashi N, Keaney JF Jr, Ruderman NB, Ido Y. AMPK inhibits fatty acid-induced increases in NF-K{green}B transactivation in cultured human umbilical vein endothelial cells. Biochem Biophys Res Commun. 2004;324:1204-1209.
25. Hostmark AT, Stensrod B, Jebens E, Lystad E, Kierulf P, Laake K. Blood reticulocyte count and plasma lactate dehydrogenase activity are positively related to the free fatty acid/albumin ratio in geriatric patients. Scand J Clin Lab Invest. 1995;55:649-653.
26. Ido Y, Carling D, Ruderman N. Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMPactivated protein kinase activation. Diabetes. 2002;51:159-167.
27. Moon A, Rhead WJ. Complementation analysis of fatty acid oxidation disorders. J Clin Invest. 1987;79:59-64.
28. Dagher Z, Ruderman N, Tornheim K, Ido Y. Acute regulation of fatty acid oxidation and AMP-activated protein kinase in human umbilical vein endothelial cells. Circ Res. 2001;88:1276-1282.
29. Seghrouchni I, Drai J, Bannier E, et al. Oxidative stress parameters in type I, type II and insulin-treated type 2 diabetes mellitus; insulin treatment efficiency. Clin Chim Acta. 2002;321:89-96.
30. Shiba T, Inoguchi T, Sportsman JR, Heath WF, Bursell S, King GL. Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation. Am J Physiol. 1993;265:E783-E793.
31. Podesta F, Romeo G, Liu WH, et al. Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro. Am J Pathol. 2000;156:1025-1032.
32. Romeo G, Liu WH, Asnaghi V, Kern TS, Lorenzi M. Activation of nuclear factor-K{green}B induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes. 2002;51: 2241-2248.
33. Boland MP, O'Neill LA. Ceramide activates NFK{green}B by inducing the processing of p105. J Biol Chem. 1998;273:15494-15500.
34. Wang YM, Seibenhener ML, Vandenplas ML, Wooten MW. Atypical PKC zeta is activated by ceramide, resulting in coactivation of NF-K{green}B/JNK kinase and cell survival. J Neurosci Res. 1999;55:293-302.
35. Hennig B, Toborek M, Joshi-Barve S, et al. Linoleic acid activates nuclear transcription factor-kappa B (NF-kappa (B) and induces NF-kappa B-dependent transcription in cultured endothelial cells. Am J Clin Nutr. 1996;63:322-328.
36. Saitoh Y, Chun-ping C, Noma K, Ueno H, Mizuta M, Nakazato M. Pioglitazone attenuates fatty acid-induced oxidative stress and apoptosis in pancreatic beta-cells. Diabetes Obes Metab. 2008; 10:564-573.
37. Swagell CD, Henly DC, Morris CP. Expression analysis of a human hepatic cell line in response to palmitate. Biochem Biophys Res Commun. 2005;328:432-441.
38. Blazquez C, Geelen MJ, Velasco G, Guzman M. The AMP-activated protein kinase prevents ceramide synthesis de novo and apoptosis in astrocytes. FEBS Lett. 2001;489:149-153.
39. Kim JE, Ahn MW, Baek SH, et al. AMPK activator, AICAR, inhibits palmitate-induced apoptosis in osteoblast. Bone. 2008;43:394-404.
40. Borradaile NM, Han X, Harp JD, Gale SE, Ory DS, Schaffer JE. Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death. J Lipid Res. 2006;47:2726-2737.
41. Cacicedo J, Keaney J Jr, Ruderman N, Ido Y. Activation of AMPactivated protein kinase (AMPK) in human umbilical vein endothelial cells (HUVEC) prevents palmitate-induced increases in oxidative stress and apoptosis. Diabetes. 2005;54(suppl):A480.
42. Yu HY, Inoguchi T, Kakimoto M, et al. Saturated non-esterified fatty acids stimulate de novo diacylglycerol synthesis and protein kinase C activity in cultured aortic smooth muscle cells. Diabetologia. 2001;44:614-620.
43. Shojaee N, Patton WF, Hechtman HB, Shepro D. Myosin translocation in retinal pericytes during free-radical induced apoptosis. J Cell Biochem. 1999;75:118-129.
44. Kukidome D, Nishikawa T, Sonoda K, et al. Activation of AMPactivated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells. Diabetes. 2006;55:120-127.
45. Ceolotto G, Gallo A, Papparella I, et al. Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD(P)H oxidase via AMPK-dependent mechanism. Arterioscler Thromb Vasc Biol. 2007;27:2627-2633.
46. Gudz TI, Tserng KY, Hoppel CL. Direct inhibition of mitochondrial respiratory chain complex III by cell-permeable ceramide. J Biol Chem. 1997;272:24154-24158.
47. Kolesnick RN, Kronke M. Regulation of ceramide production and apoptosis. Annu Rev Physiol. 1998;60:643-665.
48. Koves TR, Ussher JR, Noland RC, et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 2008;7:45-56.
49. Hardie DG. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol. 2007;8:774-785.
50. Towler MC, Hardie DG. AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res. 2007;100:328-341.
51. Guigas B, Bertrand L, Taleux N, et al. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMP-activated protein kinase-independent effect on glucokinase translocation. Diabetes. 2006;55:865-874.
52. Devaraj S, Torok N, Dasu MR, Samols D, Jialal I. Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells: evidence for an adipose tissue-vascular loop. Arterioscler Thromb Vasc Biol. 2008;28:1368-1374.
53. Musi N, Hayashi T, Fujii N, Hirshman MF, Witters LA, Goodyear LJ. AMP-activated protein kinase activity and glucose uptake in rat skeletal muscle. Am J Physiol Endocrinol Metab. 2001;280:E677-E684.
54. Theodoropoulou S, Kolovou PE, Morizane Y, et al. Retinoblastoma cells are inhibited by aminoimidazole carboxamide ribonucleotide (AICAR) partially through activation of AMP-dependent kinase. FASEB J. 2010;24:2620-2630.
55. Gao XY, Kuang HY, Zou W, Liu XM, Lin HB, Yang Y. The timing of re-institution of good blood glucose control affects apoptosis and expression of Bax and Bcl-2 in the retina of diabetic rats. Mol Biol Rep. 2009;36:1977-1982.
56. Kern TS. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res. 2007;2007:95103.